Key Record Dates
ClinicalTrials.gov Identifier: | NCT03260023 |
---|---|
Brief Title: | Phase Ib/II of TG4001 and Avelumab in HPV16 Positive R/M Cancers |
First Submitted : | August 17, 2017 |
First Submitted that Met QC Criteria : | August 23, 2017 |
First Posted : | August 24, 2017 |
Last Update Submitted that Met QC Criteria : | February 14, 2022 |
Last Update Posted : | February 15, 2022 |